Opioids and frequency counts in the US Food and Drug Administration Adverse Event Reporting System (FAERS) database: a quantitative view of the epidemic
Michael A Veronin,1 Robert P Schumaker,2 Rohit R Dixit,2 Harshini Elath21Social and Administrative Sciences, Department of Pharmaceutical Sciences, University of Texas at Tyler, Ben and Maytee Fisch College of Pharmacy, Tyler, TX 75799, USA; 2Department of Computer Science, College of Business and T...
Main Authors: | Veronin MA, Schumaker RP, Dixit RR, Elath H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-08-01
|
Series: | Drug, Healthcare and Patient Safety |
Subjects: | |
Online Access: | https://www.dovepress.com/opioids-and-frequency-counts-in-the-us-food-and-drug-administration-ad-peer-reviewed-article-DHPS |
Similar Items
-
Retrospective analysis of adverse events with spironolactone in females reported to the United States Food and Drug Administration
by: Yu Wang, BA, et al.
Published: (2020-09-01) -
Cardiovascular Toxicity of Tyrosine Kinase Inhibitors Used in Chronic Myeloid Leukemia: An Analysis of the FDA Adverse Event Reporting System Database (FAERS)
by: Santa Cirmi, et al.
Published: (2020-03-01) -
The Impact of the Sentinel Initiative and FAERS Surveillance System on Consumer Safety
by: Batra, Sonia
Published: (2016) -
Mining and visualizing high-order directional drug interaction effects using the FAERS database
by: Xiaohui Yao, et al.
Published: (2020-03-01) -
Relevance of the Weber effect in contemporary pharmacovigilance of oncology drugs
by: Arora A, et al.
Published: (2017-09-01)